A detailed history of Fmr LLC transactions in Care Dx, Inc. stock. As of the latest transaction made, Fmr LLC holds 69,320 shares of CDNA stock, worth $2.07 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
69,320
Previous 64,505 7.46%
Holding current value
$2.07 Million
Previous $683,000 57.54%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$7.56 - $16.15 $36,401 - $77,762
4,815 Added 7.46%
69,320 $1.08 Million
Q1 2024

May 13, 2024

SELL
$7.96 - $12.37 $1,122 - $1,744
-141 Reduced 0.22%
64,505 $683,000
Q4 2023

Feb 13, 2024

SELL
$4.9 - $12.86 $28,184 - $73,970
-5,752 Reduced 8.17%
64,646 $775,000
Q3 2023

Nov 13, 2023

BUY
$7.0 - $11.26 $22,211 - $35,727
3,173 Added 4.72%
70,398 $492,000
Q2 2023

Aug 11, 2023

BUY
$7.61 - $9.46 $196,102 - $243,774
25,769 Added 62.16%
67,225 $571,000
Q1 2023

May 11, 2023

SELL
$8.83 - $17.61 $7,002 - $13,964
-793 Reduced 1.88%
41,456 $378,000
Q4 2022

Feb 13, 2023

BUY
$10.88 - $20.05 $167,356 - $308,409
15,382 Added 57.25%
42,249 $482,000
Q3 2022

Nov 10, 2022

BUY
$16.06 - $26.39 $335,894 - $551,946
20,915 Added 351.39%
26,867 $457,000
Q2 2022

Aug 12, 2022

SELL
$20.49 - $39.72 $459,775 - $891,277
-22,439 Reduced 79.04%
5,952 $128,000
Q1 2022

May 13, 2022

SELL
$28.19 - $46.6 $1.34 Million - $2.22 Million
-47,610 Reduced 62.64%
28,391 $1.05 Million
Q4 2021

Feb 14, 2022

SELL
$41.2 - $73.6 $4.25 Million - $7.59 Million
-103,172 Reduced 57.58%
76,001 $3.46 Million
Q3 2021

Nov 15, 2021

SELL
$59.15 - $91.99 $11,001 - $17,110
-186 Reduced 0.1%
179,173 $11.4 Million
Q2 2021

Aug 13, 2021

BUY
$63.02 - $95.11 $11.3 Million - $17.1 Million
179,359 New
179,359 $16.4 Million

Others Institutions Holding CDNA

About CareDx, Inc.


  • Ticker CDNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 53,458,100
  • Market Cap $1.6B
  • Description
  • CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers worldwide. It provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for...
More about CDNA
Track This Portfolio

Track Fmr LLC Portfolio

Follow Fmr LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fmr LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fmr LLC with notifications on news.